Please note that Mr. Sachin Mehta has resigned as Chief Financial Officer w.e.f. 01-05-2026. He shall continue as Joint Managing Director of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sachin Mehta has resigned as Chief Financial Officer of Sudarshan Pharma Industries Ltd, effective 1 May 2026. He will continue serving as Joint Managing Director of the company. The resignation has been submitted voluntarily by Mr. Mehta. The filing also discloses that Mr. Sachin Mehta is a relative of Mr. Hemal Mehta, Chairman & Managing Director of the company. The company has filed this intimation under SEBI Listing Regulations, 2015, with BSE Limited (Scrip Code: 543828).
The CFO departure creates a key management gap that needs to be filled, but the continuity of Mr. Mehta as Joint Managing Director provides some stability. Investors should monitor for appointment of a new CFO, as this is a critical finance leadership role.